Amino Acids

, Volume 46, Issue 4, pp 901–909 | Cite as

Hylaranins: prototypes of a new class of amphibian antimicrobial peptide from the skin secretion of the oriental broad-folded frog, Hylarana latouchii

  • Yan Lin
  • Nan Hu
  • Peng Lyu
  • Jie Ma
  • Lei Wang
  • Mei ZhouEmail author
  • Suhua GuoEmail author
  • Tianbao Chen
  • Chris Shaw
Original Article


Amphibian skin secretions contain a broad spectrum of biologically active compounds, particularly antimicrobial peptides, which are considered to constitute a first line of defence against bacterial infection. Here we describe the identification of two prototype peptides representing a novel structural class of antimicrobial peptide from the skin secretion of the oriental broad-folded frog, Hylarana latouchii. Named hylaranin-L1 (GVLSAFKNALPGIMKIIVamide) and hylaranin-L2 (GVLSVIKNALPGIMRFIAamide), both peptides consist of 18 amino acid residues, are C-terminally amidated and are of unique primary structures. Their primary structures were initially deduced by MS/MS fragmentation sequencing from reverse-phase HPLC fractions of skin secretion that demonstrated antimicrobial activity. Subsequently, their precursor-encoding cDNAs were cloned from a skin secretion-derived cDNA library and their primary structures were confirmed unequivocally. Synthetic replicates of both peptides exhibited broad-spectrum antimicrobial activity with mean inhibitory concentrations (MICs) of 34 μM against Gram-negative Escherichia coli, 4.3 μM against Gram-positive Staphylococcus aureus and 4–9 μM against the yeast, Candida albicans. Both peptides exhibited little haemolytic activity (<6 %) at the MICs for S. aureus and C. albicans. Amphibian skin secretions thus continue to provide novel antimicrobial peptide structures that may prove to be lead compounds in the design of new classes of anti-infection therapeutics.


Amphibian Antimicrobial Peptide Molecular cloning Mass spectrometry 


Conflict of interest

The authors declare that they have no conflict of interests.


  1. Arnold K, Bordoli L, Kopp J, Schwede T (2006) The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 22:195–201PubMedCrossRefGoogle Scholar
  2. Bevins CL, Zasloff M (1990) Peptides from frog skin. Annu Rev Biochem 59:395–414PubMedCrossRefGoogle Scholar
  3. Bowie JH, Separovic F, Tyler MJ (2012) Host-defense peptides of Australian anurans. Part 2. Structure, activity, mechanism of action, and evolutionary significance. Peptides 37:174–188PubMedCrossRefGoogle Scholar
  4. Conlon JM (2011) Structural diversity and species distribution of host-defense peptides in frog skin secretions. Cell Mol Life Sci 68:2303–2315PubMedCrossRefGoogle Scholar
  5. Conlon JM, Kolodziejek J, Nowotny N (2004) Antimicrobial peptides from ranid frogs: taxonomic and phylogenetic markers and a potential source of new therapeutic agents. Biochim Biophys Acta 1696:1–14PubMedCrossRefGoogle Scholar
  6. Davies J, Davies D (2010) Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev 74:417–433PubMedCentralPubMedCrossRefGoogle Scholar
  7. Erspamer V (1994) Bioactive secretions of the integument, amphibian biology. In: Heatwole H, Barthalmus T (eds) The integument, vol 1. Surrey Beatty and Sons, Chipping Norton, pp 178–350Google Scholar
  8. Hancock REW (2000) Cationic antimicrobial peptides, towards clinical applications. Expert Opin Investig Drugs 9:1723–1729PubMedCrossRefGoogle Scholar
  9. Haney EF, Hunter HN, Matsuzaki K, Vogel HJ (2009) Solution NMR studies of amphibian antimicrobial peptides: linking structure to function? Biochim Biophys Acta 1788:1639–1655PubMedCrossRefGoogle Scholar
  10. Matsuzaki K (1999) Why and how are peptide–lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. Biochim Biophys Acta 1462:1–10PubMedCrossRefGoogle Scholar
  11. Park Y, Hahm KS (2005) Antimicrobial peptides (AMPs): peptide structure and mode of action. J Biochem Mol Biol 38:507–516PubMedCrossRefGoogle Scholar
  12. Rinaldi AC (2002) Antimicrobial peptides from amphibian skin: an expanding scenario. Curr Opin Chem Biol 6:799–804PubMedCrossRefGoogle Scholar
  13. Saleem M, Nazir M, Ali MS, Hussain H, Lee YS, Riaz N, Jabbar A (2010) Antimicrobial natural products: an update on future antibiotic drug candidates. Nat Prod Rep 27:238–254PubMedCrossRefGoogle Scholar
  14. Simmaco M, Mignogna G, Barra D (1998) Antimicrobial peptides from amphibian skin: what do they tell us? Biopolymers 47:435–450PubMedCrossRefGoogle Scholar
  15. Teixeira V, Feio MJ, Bastos M (2012) Role of lipids in the interaction of antimicrobial peptides with membranes. Prog Lipid Res 51:149–177PubMedCrossRefGoogle Scholar
  16. Thomas P, Kumar TV, Reshmy V, Kumar KS, George S (2012) A mini review on the antimicrobial peptides isolated from the genus Hylarana (Amphibia: Anura) with a proposed nomenclature for amphibian skin peptides. Mol Biol Rep 39:6943–6947PubMedCrossRefGoogle Scholar
  17. Tyler MJ, Stone DJM, Bowie JH (1992) A novel method for the release and collection of dermal, glandular secretions from the skin of frogs. J Pharmacol Toxicol Methods 28:199–200PubMedCrossRefGoogle Scholar
  18. Wang H, Li R, Xi X, Meng T, Zhou M, Wang L, Zhang Y, Chen T, Shaw C (2013) Senegalin: a novel antimicrobial/myotropic hexadecapeptide from the skin secretion of the African running frog, Kassina senegalensis. Amino Acids 44:1347–1355PubMedCrossRefGoogle Scholar
  19. Yeaman MR, Yount NY (2003) Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev 55:27–55PubMedCrossRefGoogle Scholar
  20. Yount NY, Bayer AS, Xiong YQ, Yeaman MR (2006) Advances in antimicrobial peptide immunobiology. Biopolymers 84:435–458PubMedCrossRefGoogle Scholar
  21. Zasloff M (1987) Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci USA 84:5449–5453PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 2013

Authors and Affiliations

  1. 1.Natural Drug Discovery Group, School of PharmacyQueen’s UniversityBelfastNorthern Ireland, UK
  2. 2.Fujian Health CollegeFuzhouPeople’s Republic of China

Personalised recommendations